Human Papilloma Virus
Papillomaviruses are a diverse group of DNA-based viruses that infect the skin and mucous membranes of humans and a variety of animals. More than 100 different human papillomavirus (HPV) types have been characterized. Some HPV types cause benign skin warts, or papillomas, for which the virus family is named. HPVs associated with the development of such "common warts" are transmitted environmentally or by casual skin-to-skin contact.
A separate group of about 30 HPVs are typically transmitted through sexual contact. Genital HPV infection is very common, with estimates suggesting that more than 50% of women will become infected with one or more of the sexually transmitted HPV types at some point during adulthood. The American Social Health Association projections in 2006 were yet more pessimistic, predicting that about 75% of the reproductive population will have been infected with genital HPV infection in their lifetime. Some sexually transmitted HPVs, such as types 6 and 11, can cause genital warts. However, most HPV types that infect the genitals tend not to cause noticeable symptoms. Persistent infection with a subset of about a dozen so-called "high-risk" sexually transmitted HPVs, including types 16, 18, 31, 33, 35, 39, 45 and 51 can lead to the development of cervical dyskaryosis, which may in turn lead to cancer of the cervix. HPV infection is a necessary factor in the development of nearly all cases of cervical cancer.
Cervical Pap smear testing is used to detect HPV-induced cellular abnormalities. This allows targeted surgical removal of pre-cancerous lesions prior to the development of invasive cervical cancer. In the absence of Pap testing or treatment, about 1% of women with genital HPV infections will eventually go on to develop cervical cancer. Although the widespread use of Pap testing has reduced the incidence and lethality of cervical cancer in developed countries, the disease still kills several hundred thousand women per year worldwide. A recently approved HPV vaccine that blocks initial infection with several of the most common sexually transmitted HPV types may lead to further decreases in the incidence of HPV-induced cancer.
...More at Wikipedia
Related Links:
Human Papilloma Virus
Questions recently asked by other users
Latest Cervical Cancer / HPV Vaccine News From Medical News Today.
- Case Strengthens For HPV Vaccination In Boys
- South African Advocacy Group Calls For Increased HPV Vaccinations Of HIV-Positive Women
- Four-type HPV Vaccine Gardasil(R) Is Also Effective In Men
- New Research Shows Knowledge Of HPV And Vaccination Could Improve Cervical Screening Attendance
- New Data On Cancer Diagnostic Presented By Arbor Vita
- GARDASIL(R) Demonstrated Efficacy In Preventing HPV-Related Disease In Males In Phase III Study
- Researchers Say Identification Of Women With HPV Types 16, 18 And 45 Could Improve Early Intervention To Stop Cervical Cancer
- Study Finds HPV Vaccine Gardasil Effective At Preventing Male Genital Lesions
- Modelling Research Shows CervarixTM-induced Immune Response May Be Prolonged For At Least 20 Years For Both HPV 16 And 18
- Hologic Releases The Results Of The Cervista(TM) HPV Clinical Trials
- Making HPV Vaccination Mandatory Is Unwarranted And Unwise
